Craig-Hallum analyst Albert Lowe reiterated a Buy rating and $10.00 price target on Cardiff Oncology (NASDAQ: CRDF)The analyst commented, "CRDF ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE